Poomchaichote Tassawan, Osterrieder Anne, Prapharsavat Ravikanya, Naemiratch Bhensri, Ruangkajorn Supanat, Thirapantu Chaiwat, Sukrung Karnjariya, Kiatying-Angsulee Niyada, Sumpradit Nithima, Punnin Sirima, Limmathurotsakul Direk, Cheah Phaik Yeong
Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Wellcome Open Res. 2022 Apr 7;6:188. doi: 10.12688/wellcomeopenres.17066.2. eCollection 2021.
The use of antimicrobials in Thailand has been reported as one of the highest in the world in both the human and animal sectors. The objectives of this project are: (1) to improve understanding of the issue of antimicrobial resistance (AMR) among adult Thai communities and (2) to drive change through the national AMR policy to include context-specific and locally-driven solutions. The project contains two components conducted in parallel: the "AMR Dialogues" public engagement project and the embedded evaluation of the project. We will bring together AMR stakeholders and members of the public through a series of conversation events to co-create an AMR stakeholder map, engagement strategy, and context-specific solutions to reduce the burden of AMR. There will be a combination of regional in-person events ('regional conversations') and national online events ('national conversations') with members of the public and AMR stakeholders. The conversations will follow this sequence: introduce and explore issues related to AMR, brainstorm solutions and finally propose promising/feasible solutions to take forward. Evaluation of the project will be conducted to assess if the AMR Dialogues objectives have been achieved using feedback forms and qualitative methods. Approval of the evaluation component of the project has been obtained from the ethics committee of the Thailand Institute for the Development of Human Subject Protection (IHRP2021059) and the Oxford University Tropical Research Ethics Committee (OxTREC 529-21). The results of these conversation events will inform the next Thailand National Strategic Plan on AMR. The learning and outcomes will be disseminated to AMR policy makers, academic audiences, and participants of all the conversation events. TCTR20210528003 (28/05/2021).
据报道,泰国在人类和动物领域使用抗菌药物的情况位居世界前列。该项目的目标是:(1)增进泰国成年人群体对抗菌药物耐药性(AMR)问题的了解;(2)通过国家AMR政策推动变革,纳入因地制宜、由地方主导的解决方案。该项目包含两个并行开展的部分:“AMR对话”公众参与项目以及项目的嵌入式评估。我们将通过一系列对话活动,召集AMR利益相关者和公众,共同创建AMR利益相关者地图、参与策略以及因地制宜的解决方案,以减轻AMR负担。将举办一系列区域性线下活动(“区域对话”)和全国性线上活动(“全国对话”),参与对象包括公众和AMR利益相关者。对话将按以下顺序进行:介绍并探讨与AMR相关的问题、集思广益提出解决方案,最后提出有前景/可行的推进方案。将对该项目进行评估,通过反馈表和定性方法评估“AMR对话”的目标是否实现。该项目评估部分已获得泰国人类受试者保护发展研究所伦理委员会(IHRP2021059)和牛津大学热带研究伦理委员会(OxTREC 529 - 21)的批准。这些对话活动的结果将为下一份泰国国家AMR战略计划提供参考。研究成果将向AMR政策制定者、学术受众以及所有对话活动的参与者进行传播。TCTR20210528003(2021年5月28日)